SCHEMBL14301045

SCHEMBL14301045

CCc1cc(O)c(CO)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.50
MAPK1 P28482 2/20 0.45
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
BACE1 P56817 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ALOX5 P09917 1/20 0.38
GAA P10253 1/20 0.38
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
HSPA5 P11021 1/20 0.35
ACHE P22303 1/20 0.35
ALOX15 P16050 3/20 0.34
IGF1R P08069 2/20 0.34
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1179394 0.84 TRPA1 (0.54) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL9745054 0.78 NPC1 (0.59) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL16528474 0.78 TRPA1 (0.48) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL992788 0.76 TRPA1 (0.46) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL1173818 0.76 TRPA1 (0.56) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL508967 0.75 HSPA5 (0.39) TRPA1HPGDBACE1MAPTKDM4E
SCHEMBL14304473 0.75 HSPA5 (0.39) TRPA1HPGDBACE1MAPTKDM4E
SCHEMBL9744115 0.75 NPC1 (0.80) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL3182711 0.74 SELL (0.52) TRPA1MAPK1NPC1HPGDHTT
SCHEMBL67845 0.74 TRPA1 (0.54) TRPA1MAPK1NPC1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051326-A1 Antiinfective Lipopeptides CUBIST PHARMACEUTICALS, INC. 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051326-A1 Antiinfective Lipopeptides VIP, NGLY1, PREP TRPA1 3083/4885MAPK1 3260/4885NPC1 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.